Skip to content

HPLC Purity and Peptide Content Are Different Measurements

A chromatographic percentage and an amount of material have different denominators. Neither should be silently substituted for the other.

By Peptide Mag Editorial. Updated . Source and review policy.

Two questions, not one

A purity test describes the sample under the conditions and scope of its analytical method. A content or assay measurement asks how much of a defined analyte is present on a stated basis. The word purity does not tell you the answer to both questions.

For an HPLC area percentage, first determine what peaks were integrated and how the method detects the compounds. Do not assume the denominator is the total weight of a vial. Water, counterions, excipients and components with different analytical responses require separate consideration.

A numerical example

Imagine a hypothetical report showing a target peak accounting for 99% of integrated detector area, while a separate validated assay reports 8 mg of target analyte in a submitted sample. These results are not inherently contradictory: one describes an area ratio, the other an amount. This is a teaching example, not a statement about any vendor's product.

ResultDenominator or basisCannot be inferred automatically
99% target peak areaThe integrated signals included by that method99% of total vial weight is active peptide
8 mg analyte per submitted sampleThe calibrated assay's stated sample basisIdentical content in every other vial
A matching mass signalThe identity test and its resolutionSterility or clinical safety

Ask for the basis of the result

A useful report identifies the method, reference material where applicable, sample preparation, units and result basis. If a percentage is reported without those details, the next step is clarification—not conversion into milligrams.

ICH Q2(R2) distinguishes analytical purposes such as identity, impurity, content and potency. The broader lesson is to choose a method that answers the intended question and verify its performance for that purpose.

Keep quality and clinical claims separate

Even well-characterized material does not become a clinically validated treatment because its laboratory report looks strong. Chemical identity, quantity, microbiological quality and evidence for a proposed use remain separate questions.

Use the report to make the narrowest conclusion it supports. Do not turn a result for a submitted sample into a claim that every lot or batch was tested, or that an unstudied blend inherits the efficacy of each named component.

Sources and further reading

  1. ICH Q2(R2) — analytical procedure validation

Continue reading